157 related articles for article (PubMed ID: 18091745)
1. Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.
Canzanello VJ; Baranco-Pryor E; Rahbari-Oskoui F; Schwartz GL; Boerwinkle E; Turner ST; Chapman AB
Am J Hypertens; 2008 Jan; 21(1):61-6. PubMed ID: 18091745
[TBL] [Abstract][Full Text] [Related]
2. Plasma renin activity for predicting antihypertensive drug efficacy.
Blumenfeld JD
Am J Hypertens; 2008 Jan; 21(1):5-6. PubMed ID: 18091734
[No Abstract] [Full Text] [Related]
3. The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.
Schwartz GL; Bailey K; Chapman AB; Boerwinkle E; Turner ST
Am J Hypertens; 2013 Aug; 26(8):957-64. PubMed ID: 23591988
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
Minami J; Ishimitsu T; Matsuoka H
Am J Hypertens; 2008 Jan; 21(1):10-3. PubMed ID: 18091737
[TBL] [Abstract][Full Text] [Related]
5. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
[TBL] [Abstract][Full Text] [Related]
6. Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.
Sakima A; Kita T; Nakada S; Yokota N; Tamaki N; Etoh T; Shimokubo T; Kitamura K; Takishita S; Ohya Y
Clin Exp Hypertens; 2014; 36(1):40-5. PubMed ID: 23713902
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension.
Papademetriou V; Narayan P; Kokkinos P
J Clin Hypertens (Greenwich); 2004 Jun; 6(6):310-4. PubMed ID: 15187493
[TBL] [Abstract][Full Text] [Related]
8. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
Turner ST; Bailey KR; Schwartz GL; Chapman AB; Chai HS; Boerwinkle E
Hypertension; 2012 Jun; 59(6):1204-11. PubMed ID: 22566498
[TBL] [Abstract][Full Text] [Related]
9. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
Sever PS; Chang CL
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
12. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
[TBL] [Abstract][Full Text] [Related]
15. Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
Cunningham PN; Wang Z; Grove ML; Cooper-DeHoff RM; Beitelshees AL; Gong Y; Gums JG; Johnson JA; Turner ST; Boerwinkle E; Chapman AB
PLoS One; 2019; 14(9):e0221957. PubMed ID: 31532792
[TBL] [Abstract][Full Text] [Related]
16. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Lee HY; Hong BK; Chung WJ; Lee BK; Lee SH; Jeon DW; Ahn YK; Kim D; Park CK; Kim SH; Jung HO; Kim BO; Choi D
Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
[TBL] [Abstract][Full Text] [Related]
17. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.
Sakamoto M; Suzuki H; Hayashi T; Iuchi H; Isaka T; Sakamoto N; Kayama Y; Tojo K; Yoshimura M; Utsunomiya K
Cardiovasc Diabetol; 2012 Oct; 11():118. PubMed ID: 23034088
[TBL] [Abstract][Full Text] [Related]
19. Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis.
Mori-Takeyama U; Minatoguchi S; Murata I; Fujiwara H; Ozaki Y; Ohno M; Oda H; Ohashi H
Clin Exp Nephrol; 2008 Feb; 12(1):33-40. PubMed ID: 18175062
[TBL] [Abstract][Full Text] [Related]
20. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
